Not the best name for a company given the epidemic, but Ro, which basically sells health products over the internet, is acquiring Modern Fertility. Here is the insanity of current investing. Ro raised an astounding $500 million earlier this year. It is spending $225 million to buy Modern Fertility which offers fertility tests. So the Modern Fertility shareholders are happy because they took their crappy investment and made money, but the Ro shareholders should be livid, because there is no way you get a return on either the $500 million or the $225 million.
Cedar seeks its way out of the forest by spending $425 million to acquire OODA Health, creating a firm which offers billing and revenue cycle services to providers and payers.
Unmind, which offers mental health support services in the workplace, raises $47 million in a new financing from investors who are apparently un-minded.
Hospitals are an expensive health care setting, so for decades policy has attempted to lessen hospital use, which has some unintended consequences, as revealed by the epidemic. One emerging trend has been "hospital at home", in which all the expensive equipment is placed, and monitoring of a patient is literally done, at their home. Mayo Clinic and Kaiser have both invested in a company facilitating hospital at home capabilities, putting as much as $100 million into Medically Home Group.
Health care is a fifth of the economy. Everyone wants a piece, including Walmart, which just purchased a telemedicine company, MeMD, for an undisclosed sum. Walmart has increasingly added health care services to its original pharmacy business, including in-store clinics. At least with Walmart, health care probably is made more affordable.
Vida Health comes alive with a $110 million capital raise to support its business of offering apps to help manage chronic health conditions. It only competes with a hundred other companies offering the same low value crap, so you can understand why investors jumped at the chance to put more money in.
Collective Health aggregates $280 million in new financing to support its employer health benefits management business. The investors have lost their collective minds. The company serves employers with 300,000 members in 55 companies, so it is being valued at about $1000 a member for a commodity business.
R1 RCM, a vendor of provider revenue cycle management software and services, is paying a healthy $300 million to buy VisitPay, which helps patients figure out to pay what they owe for health care services.
Headway has raised $70 million in new capital to facilitate growth of its platform to assist therapists in providing mental health services and patients in finding therapists.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.